September 24, 2024 11:45 ET | Source: Transgene S.A. Transgene S.A.
2024 Half Year Financial Report
Attachment
Transgene to Participate in Upcoming Investor Meetings
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
